BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34362013)

  • 21. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
    Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
    Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.
    Thway K; Wang J; Swansbury J; Min T; Fisher C
    Sarcoma; 2015; 2015():812089. PubMed ID: 25810689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient.
    Kukull BJ; Khalighi MA; Gundle KR; Hansford BG; Corless CL; Davis JL
    Pediatr Dev Pathol; 2020; 23(3):240-246. PubMed ID: 31739757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limb Salvage Resection of Massive Dedifferentiated Thigh Liposarcoma in a Patient Lost to Follow-Up.
    Calvo NJ; Mann AJ; Lopez-Viego M; Genuit T
    Cureus; 2021 Feb; 13(2):e13356. PubMed ID: 33754090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
    Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
    Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma.
    Horvai AE; DeVries S; Roy R; O'Donnell RJ; Waldman F
    Mod Pathol; 2009 Nov; 22(11):1477-88. PubMed ID: 19734852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
    Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
    Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
    Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G
    J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time polymerase chain reaction analysis of MDM2 and CDK4 expression using total RNA from core-needle biopsies is useful for diagnosing adipocytic tumors.
    Sasaki T; Ogose A; Kawashima H; Hotta T; Hatano H; Ariizumi T; Umezu H; Ohashi R; Tohyama T; Tanabe N; Endo N
    BMC Cancer; 2014 Jun; 14():468. PubMed ID: 24965044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.
    Erickson-Johnson MR; Seys AR; Roth CW; King AA; Hulshizer RL; Wang X; Asmann YW; Lloyd RV; Jacob EK; Oliveira AM
    Mod Pathol; 2009 Dec; 22(12):1541-7. PubMed ID: 19820690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double minute chromosomes harboring MDM2 amplification in a pediatric atypical lipomatous tumor.
    Dadone-Montaudié B; Burel-Vandenbos F; Soler C; Rosello O; Boyer C; Fabas T; Bianchini L; Pedeutour F
    Genes Chromosomes Cancer; 2019 Sep; 58(9):673-679. PubMed ID: 30887579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma with Myxoid Stroma in a Hereditary Retinoblastoma Survivor.
    Peck T; Gervasio KA; Zhang PJL; Shields CL; Lally SE; Eagle RC; Milman T
    Ocul Oncol Pathol; 2020 Mar; 6(2):79-86. PubMed ID: 32258014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
    Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
    Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma.
    Mantilla JG; Ricciotti RW; Chen EY; Liu YJ; Hoch BL
    Mod Pathol; 2019 Apr; 32(4):585-592. PubMed ID: 30420727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous Tumors.
    Pei J; Flieder DB; Talarchek JN; Cooper HS; Patchefsky AS; Wei S
    Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):592-598. PubMed ID: 33734108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
    Alshenawy H
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
    Chambers M; Badin DJ; Sriharan AA; Linos KD
    J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case Report: Primary low-grade dedifferentiated liposarcoma of the urinary bladder with molecular confirmation.
    Cui J; Peng R; Zhang Y; Lu Y; He X; Chen M; Zhang H
    Front Oncol; 2023; 13():1221027. PubMed ID: 37881487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases.
    Lokka S; Scheel AH; Dango S; Schmitz K; Hesterberg R; Rüschoff J; Schildhaus HU
    BMC Clin Pathol; 2014; 14():36. PubMed ID: 25126005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.